Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(+)-α-methylphenethylamine
Dexamfetaminum
(+)-(S)-amphetamine
(αS)-α-methylbenzeneethanamine
d-amphetamine
Dextroamphetamine sulfate
Dextroamphetamine saccharate
(S)-(+)-amphetamine
Dexamfetamina
(S)-1-phenyl-2-aminopropane
Desamfetamina
(+)-amphetamine
Dextroamphetamine
(S)-α-methylbenzeneethanamine
Dexanfetamina
Dextroamphetamine adipate
Dexamphetamine
Dexamfetamine
(+)-α-methylphenylethylamine
(S)-1-phenyl-2-propylamine
(S)-(+)-β-phenylisopropylamine
(S)-amphetamine
Brand Names
Dexedrine Spansule Src 15mg
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682